Eastern Bank
PVLA icon

Eastern Bank’s Palvella Therapeutics PVLA Stock Holding History

Eastern Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.17K Hold
52
– – ﹤0.01% 956
2026
Q2 		$7.95K Buy
+52
New +$6.31K ﹤0.01% 884

Other funds holding PVLA

Clio Asset Management
Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Private Trust Company
Private Trust Company Cleveland, Ohio $1.27B AUM 20.99% 1-Year Est. Return

Eastern Bank's PVLA Position: Q3 2026 in Review

Eastern Bank held its Palvella Therapeutics (PVLA) position steady in Q3 2026 at 52 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Eastern Bank first reported a position in PVLA in Q2 2026 and has held it in 2 quarters since. The position peaked at $7.95K in Q2 2026. 22 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • Eastern Bank held 52 shares of Palvella Therapeutics worth $7.17K as of Q3 2026.
  • Eastern Bank left its Palvella Therapeutics share count unchanged in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #956 holding.
  • Eastern Bank first reported a position in Palvella Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Eastern Bank's Palvella Therapeutics position peaked at $7.95K in Q2 2026.
  • 22 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.